STOCK TITAN

[Form 4] The Joint Corp. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

The reporting person, Christopher M. Grandpre, a director of The Joint Corp. (JYNT), purchased 10,000 shares of the issuer's common stock on 08/20/2025 at a weighted-average price of $10.4082 per share. After the reported acquisition, the reporting person beneficially owns 39,383 shares in total. The filing was signed by an attorney-in-fact on 08/22/2025. The footnote clarifies the reported price is a weighted average covering multiple purchases at prices ranging from $10.30 to $10.57, and the reporting person will provide breakdowns on request.

La persona che ha effettuato la segnalazione, Christopher M. Grandpre, amministratore di The Joint Corp. (JYNT), ha acquistato 10.000 azioni del capitale sociale della società il 08/20/2025 a un prezzo medio ponderato di $10,4082 per azione. Dopo l'acquisto segnalato, la persona che ha effettuato la segnalazione detiene in totale beneficiariamente 39.383 azioni. La dichiarazione è stata firmata da un procuratore il 08/22/2025. La nota chiarisce che il prezzo indicato è una media ponderata relativa a più acquisti effettuati a prezzi compresi tra $10,30 e $10,57, e che il dichiarante fornirà i dettagli delle singole operazioni su richiesta.

La persona informante, Christopher M. Grandpre, director de The Joint Corp. (JYNT), compró 10.000 acciones del capital social de la emisora el 08/20/2025 a un precio promedio ponderado de $10.4082 por acción. Tras la adquisición reportada, la persona informante posee, de forma beneficiaria, un total de 39.383 acciones. La presentación fue firmada por un apoderado el 08/22/2025. La nota aclara que el precio comunicado es un promedio ponderado que abarca varias compras a precios entre $10,30 y $10,57, y que la persona informante facilitará el desglose si se lo solicitan.

보고자 Christopher M. Grandpre는 The Joint Corp. (JYNT)의 이사로서 발행회사의 보통주 10,000주08/20/2025에 주당 가중평균 $10.4082에 매수했습니다. 보고된 취득 후 해당 보고자는 총 39,383주를 실질적으로 보유하고 있습니다. 서류는 08/22/2025에 대리인이 서명했습니다. 각주에는 보고된 가격이 여러 매수 거래의 가격대를 반영한 가중평균(범위: $10.30~$10.57)임이 명시되어 있으며, 요청 시 개별 거래 내역을 제공하겠다고 밝혔습니다.

La personne déclarante, Christopher M. Grandpre, administrateur de The Joint Corp. (JYNT), a acheté 10 000 actions de l'actionnariat de l'émetteur le 08/20/2025 au prix moyen pondéré de 10,4082 $ par action. Après l'acquisition signalée, la personne déclarante détient en totalité, à titre bénéficiaire, 39 383 actions. Le dépôt a été signé par un mandataire le 08/22/2025. La note précise que le prix indiqué est une moyenne pondérée couvrant plusieurs achats à des prix allant de 10,30 $ à 10,57 $, et que la personne déclarante fournira la ventilation sur demande.

Die meldende Person, Christopher M. Grandpre, ein Direktor von The Joint Corp. (JYNT), erwarb am 08/20/2025 10.000 Aktien des Stammkapitals des Emittenten zu einem gewichteten Durchschnittspreis von $10,4082 je Aktie. Nach dem gemeldeten Erwerb besitzt die meldende Person insgesamt wirtschaftlich 39.383 Aktien. Die Einreichung wurde am 08/22/2025 von einem Bevollmächtigten unterzeichnet. Die Fußnote erläutert, dass der angegebene Preis ein gewichteter Durchschnitt mehrerer Käufe zu Preisen zwischen $10,30 und $10,57 ist und dass die meldende Person auf Anfrage Aufschlüsselungen bereitstellt.

Positive
  • Director open-market purchase of 10,000 shares, which increased beneficial ownership to 39,383 shares
  • Weighted-average price disclosed ($10.4082) with explicit price range ($10.30–$10.57) and offer to provide per-price breakdowns
Negative
  • None.

Insights

TL;DR: Director purchased 10,000 shares at a weighted average of $10.4082, increasing beneficial ownership to 39,383 shares.

This Form 4 reports a straightforward open-market acquisition by a director. The transaction size and post-transaction holding are explicitly stated, with a clear weighted-average purchase price and disclosed price range. For investors, insider purchases can be interpreted as a signal of confidence, but the filing contains no commentary on intent, timing beyond the trade date, or relation to broader insider trading plans.

TL;DR: A director executed multiple purchases totaling 10,000 shares; disclosure includes weighted-average pricing and availability of detailed breakdowns.

The Form 4 meets disclosure requirements by identifying the reporting person, relationship to the issuer, transaction date, amount acquired, resulting beneficial ownership, and a signed filing. The footnote proactively offers to provide per-price allocation details, which improves transparency. There is no indication of Rule 10b5-1 plan usage on the form checkbox.

La persona che ha effettuato la segnalazione, Christopher M. Grandpre, amministratore di The Joint Corp. (JYNT), ha acquistato 10.000 azioni del capitale sociale della società il 08/20/2025 a un prezzo medio ponderato di $10,4082 per azione. Dopo l'acquisto segnalato, la persona che ha effettuato la segnalazione detiene in totale beneficiariamente 39.383 azioni. La dichiarazione è stata firmata da un procuratore il 08/22/2025. La nota chiarisce che il prezzo indicato è una media ponderata relativa a più acquisti effettuati a prezzi compresi tra $10,30 e $10,57, e che il dichiarante fornirà i dettagli delle singole operazioni su richiesta.

La persona informante, Christopher M. Grandpre, director de The Joint Corp. (JYNT), compró 10.000 acciones del capital social de la emisora el 08/20/2025 a un precio promedio ponderado de $10.4082 por acción. Tras la adquisición reportada, la persona informante posee, de forma beneficiaria, un total de 39.383 acciones. La presentación fue firmada por un apoderado el 08/22/2025. La nota aclara que el precio comunicado es un promedio ponderado que abarca varias compras a precios entre $10,30 y $10,57, y que la persona informante facilitará el desglose si se lo solicitan.

보고자 Christopher M. Grandpre는 The Joint Corp. (JYNT)의 이사로서 발행회사의 보통주 10,000주08/20/2025에 주당 가중평균 $10.4082에 매수했습니다. 보고된 취득 후 해당 보고자는 총 39,383주를 실질적으로 보유하고 있습니다. 서류는 08/22/2025에 대리인이 서명했습니다. 각주에는 보고된 가격이 여러 매수 거래의 가격대를 반영한 가중평균(범위: $10.30~$10.57)임이 명시되어 있으며, 요청 시 개별 거래 내역을 제공하겠다고 밝혔습니다.

La personne déclarante, Christopher M. Grandpre, administrateur de The Joint Corp. (JYNT), a acheté 10 000 actions de l'actionnariat de l'émetteur le 08/20/2025 au prix moyen pondéré de 10,4082 $ par action. Après l'acquisition signalée, la personne déclarante détient en totalité, à titre bénéficiaire, 39 383 actions. Le dépôt a été signé par un mandataire le 08/22/2025. La note précise que le prix indiqué est une moyenne pondérée couvrant plusieurs achats à des prix allant de 10,30 $ à 10,57 $, et que la personne déclarante fournira la ventilation sur demande.

Die meldende Person, Christopher M. Grandpre, ein Direktor von The Joint Corp. (JYNT), erwarb am 08/20/2025 10.000 Aktien des Stammkapitals des Emittenten zu einem gewichteten Durchschnittspreis von $10,4082 je Aktie. Nach dem gemeldeten Erwerb besitzt die meldende Person insgesamt wirtschaftlich 39.383 Aktien. Die Einreichung wurde am 08/22/2025 von einem Bevollmächtigten unterzeichnet. Die Fußnote erläutert, dass der angegebene Preis ein gewichteter Durchschnitt mehrerer Käufe zu Preisen zwischen $10,30 und $10,57 ist und dass die meldende Person auf Anfrage Aufschlüsselungen bereitstellt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Grandpre Christopher M

(Last) (First) (Middle)
16767 NORTH PERIMETER DRIVE
SUITE 110

(Street)
SCOTTSDALE AZ 85260

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
JOINT Corp [ JYNT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/20/2025 P 10,000 A $10.4082(1) 39,383 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.30 to $10.57, inclusive. The reporting person undertakes to provide to The Joint Corp., (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Andra Terrell , as attorney-in-fact 08/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did JYNT director Christopher Grandpre report on Form 4?

The director reported acquiring 10,000 shares of JYNT common stock on 08/20/2025, bringing total beneficial ownership to 39,383 shares.

At what price were the JYNT shares purchased in the Form 4 filing?

The filing reports a weighted-average price of $10.4082 per share, with purchases made between $10.30 and $10.57.

Does the Form 4 indicate the purchase was made under a 10b5-1 plan?

The form does not indicate a transaction pursuant to a 10b5-1 plan; the 10b5-1 checkbox is not marked in the provided content.

Who signed the Form 4 for the reporting person and when?

The filing was signed by Andra Terrell, as attorney-in-fact, on 08/22/2025.

Can I obtain the detailed per-price allocation for the JYNT purchases?

Yes. The footnote states the reporting person will provide, upon request, full information on the number of shares purchased at each separate price within the disclosed range.
Joint Corp

NASDAQ:JYNT

JYNT Rankings

JYNT Latest News

JYNT Latest SEC Filings

JYNT Stock Data

157.42M
13.99M
10.38%
77.57%
3.58%
Medical Care Facilities
Patent Owners & Lessors
Link
United States
SCOTTSDALE